Tamtuvetmab [1608122-71-9]

TargetMol Chemicals

Tamtuvetmab

9

1608122-71-9

Antibody

Research Use Only

Tamtuvetmab

Tamtuvetmab (AT-005), a caninised version of blontuvetmab targeting CD52, enhances progression-free survival (PFS) and demonstrates in vivo efficacy for treating naive T-cell lymphoma (LSA) in dogs. The compound has received veterinary approval [1] [2].

3 years

-20°C

12352203